Surveillance of colorectal cancers following curative-intent surgery: "Whatever the cost?"

Affiliations

¹ EPICAD INSERM LNC-UMR 1231, Registre Bourguignon des Cancers Digestifs, Université de Bourgogne Franche Comté, Dijon, France; Department of Digestive Oncology and Hepato Gastroenterology, University Hospital of Dijon, Dijon, France. Electronic address: come.lepage@u-bourgogne.fr.
² Department of Digestive Oncology, University Hospital of Reims, Reims, France.
³ Department of Gastroenterology and Digestive Oncology, University Hospital of Saint Etienne, Saint Etienne, France.

Editorial

C Lepage et al. Dig Liver Dis. 2022 Mar.

. 2022 Mar;54(3):293-295.

doi: 10.1016/j.dld.2021.12.005. Epub 2022 Jan 10.

¹ EPICAD INSERM LNC-UMR 1231, Registre Bourguignon des Cancers Digestifs, Université de Bourgogne Franche Comté, Dijon, France; Department of Digestive Oncology and Hepato Gastroenterology, University Hospital of Dijon, Dijon, France. Electronic address: come.lepage@u-bourgogne.fr.
² Department of Digestive Oncology, University Hospital of Reims, Reims, France.
³ Department of Gastroenterology and Digestive Oncology, University Hospital of Saint Etienne, Saint Etienne, France.

No abstract available

Keywords: Colorectal cancer; Follow-up; Prodige 13; Surgery; Surveillance.

Conflict of interest statement

Declaration of Competing Interest None declared.